Glancy Binkow & Goldberg LLP Announces an Expanded Class Period in the Shareholder Lawsuit Against Nu Skin Enterprises, Inc.

Glancy Binkow & Goldberg LLP announces that the shareholder lawsuit filed against Nu Skin Enterprises, Inc. (“Nu Skin” or the “Company”) (NYSE:NUS) in the United States District Court for the District of Utah has been expanded to include all purchasers of Nu Skin securities between October 25, 2011 and January 15, 2014, inclusive (the “Class Period”).

If you purchased Nu Skin securities during the Class Period, please contact us toll-free at (888) 773-9224, or at (212) 682-5340, or by email to shareholders@glancylaw.com to discuss this matter.

Nu Skin develops and distributes anti-aging personal care products and nutritional supplements worldwide under the Nu Skin and Pharmanex brands. The Complaint alleges that the Company and certain of its executive officers misrepresented or failed to disclose that the Company’s business practices in China operated as an illegal pyramid scheme and did not comply with local laws and regulations, and the Company’s rapid growth and revenue increase could not continue without its China business.

If you purchased Nu Skin securities during the Class Period, you may move the Court no later than March 24, 2014, to serve as lead plaintiff if you meet certain legal requirements. To learn more about this action, please contact Michael Goldberg, Esquire, of Glancy Binkow & Goldberg LLP, 1925 Century Park East, Suite 2100, Los Angeles, California 90067, Toll Free at (888) 773-9224, or contact Gregory Linkh, Esquire, of Glancy Binkow & Goldberg LLP at 122 E. 42nd Street, Suite 2920, New York, New York 10168, at (212) 682-5340, by e-mail to shareholders@glancylaw.com, or visit our website at http://www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.